Marksans Pharma’s arm gets marketing authorization for Sennosides 7.5 mg Tablets

19 May 2025 Evaluate

Marksans Pharma’s wholly owned subsidiary -- Relonchem has received Marketing Authorization for the product Sennosides 7.5 mg Tablets from UK Medicines & Healthcare Products Regulatory Agency.

Earlier, Relonchem had received marketing authorization for the product Gabapentin 50 mg/ml oral solution from UK Medicines & Healthcare Products Regulatory Agency.

Marksans Pharma is engaged in Research, Manufacturing & Marketing of generic pharmaceutical formulation in the global markets.

Marksans Pharma Share Price

173.05 0.10 (0.06%)
12-Mar-2026 13:13 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1829.60
Dr. Reddys Lab 1327.40
Cipla 1329.50
Zydus Lifesciences 917.75
Lupin 2340.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×